Roffman, David A.
112  results:
Search for persons X
?
 
?
6

Developments in Oral Antiplatelet Agents for the Treatment ..:

Roffman, David S.
Journal of Pharmacy Practice.  29 (2015)  3 - p. 239-249 , 2015
 
?
7

Considerations in patients receiving oral antiplatelet ther..:

Roffman, David S.
American Journal of Health-System Pharmacy.  67 (2010)  15_Supplement_7 - p. S18-S24 , 2010
 
?
8

Aliskiren: Will a novel mechanism improve clinical outcomes:

Roffman, David S.
American Journal of Health-System Pharmacy.  65 (2008)  14 - p. 1321-1321 , 2008
 
?
9

Commentary:

Roffman, David S
Evidence-based Cardiovascular Medicine.  9 (2005)  1 - p. 39-40 , 2005
 
?
10

High- Versus Low-Dose ACE Inhibitor Therapy in Chronic Hear..:

Roffman, David S
Annals of Pharmacotherapy.  38 (2004)  5 - p. 831-838 , 2004
 
?
11

Difficulties in applying clinical trial information to the ..:

Reed, Shelby D. ; Mullins, C. Daniel ; Roffman, David S..
American Journal of Health-System Pharmacy.  55 (1998)  22 - p. 2409-2414 , 1998
 
?
 
?
 
1-15